Basic Information
Basic information for TMEM161B-AS1-226-15aa-2
Peptide Name TMEM161B-AS1-226-15aa-2
Genome Position chr5:88436591-88436635[+]
Species Human
Peptide Sequence MLFVFTKIGFNKLCD
Peptide Length 15
Unique No (TMEM161B-AS1-202-15aa-1,TMEM161B-AS1-203-15aa-1,TMEM161B-AS1-206-15aa-2,TMEM161B-AS1-210-15aa-2,TMEM161B-AS1-213-15aa-2,TMEM161B-AS1-217-15aa-3,TMEM161B-AS1-220-15aa-2,TMEM161B-AS1-224-15aa-1,TMEM161B-AS1-242-15aa-1,TMEM161B-AS1-243-15aa-2,TMEM161B-AS1-259-15aa-2)
Grand Average of Hydropathicity 0.88
Relative Molecular Mass 2028.43
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000247828;TMEM161B-AS1
Transcript ID/Name ENST00000658478;TMEM161B-AS1-226
Transcript Length 3379
Coding Ability 0.4297
DNA Sequence Corresponding to Peptide ATGTTATTTGTCTTTACAAAGATTGGTTTCAATAAACTGTGTGAC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :